---
category: news
title: "Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights"
excerpt: "DALLAS, May 3, 2022 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I ... the potential of combination therapy for these two agents."
publishedDateTime: 2022-05-03T23:30:00Z
originalUrl: "https://www.kron4.com/business/press-releases/cision/20220503DA44966/lantern-pharma-reports-first-quarter-2022-financial-results-and-operational-highlights/"
webUrl: "https://www.kron4.com/business/press-releases/cision/20220503DA44966/lantern-pharma-reports-first-quarter-2022-financial-results-and-operational-highlights/"
type: article

provider:
  name: KRON4
  domain: kron4.com

topics:
  - AI in Healthcare
  - AI

secured: "yfHBM2Qvk1rqI74jrCaIopXzcLDCNrgA0siVYsH1EsYVfIbCSHp+azqqpFwguVVDo82oYsFSN0cFS2kkB96chkYqlzQmsNV9lBgzbvTjOyPctbaNkw0/7scvTDSvRd8MxZlp/XjKzKXkMhKoIzJI6a+EFbGU8cFtY9TC/I99Fm6k3YFTLuCVSGRsPjmmOHeBhPsYDHZkCXDcr8SqL/3E5AcinI2LAIg5YhnsepV+v/JCRPj7vFl+LitikhR21N+xtipKPJkye1MXHvs0vaMwBJyFCeaVDtyOkTvXUl3a7kvQWnkbRMNg7LGNPpvG+LFHkwIvDeXRcMKPIycx6fL0HRWuij80/4f2NZa7E0oo8uE=;ll3KsmluS4iirT8pkYSjAw=="
---

